Sheri Shaw
Psychiatric/Mental Health · Waco, TXNPI 1972142164
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 213 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 23.4% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 213 payments — averaging $60.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$3K
- AbbVie$3K
- Neurocrine Biosciences, Inc.$2K
- Otsuka America Pharmaceutical, Inc.$1K
- Johnson & Johnson$1K
- Alkermes, Inc.$1K
- plus $1K from 5 others
What the payments were for
- Food & beverage$12,58098%
- Education$1992%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 41 | $2,988 |
| AbbVie | 38 | $2,945 |
| Neurocrine Biosciences, Inc. | 33 | $2,162 |
| Otsuka America Pharmaceutical, Inc. | 29 | $1,279 |
| Johnson & Johnson | 35 | $1,192 |
| Alkermes, Inc. | 15 | $1,064 |
| Axsome Therapeutics, Inc. | 4 | $349 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $329 |
| E.r. Squibb & Sons, L.L.C. | 3 | $315 |
| Sunovion Pharmaceuticals Inc. | 8 | $135 |
| Lundbeck LLC | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$2,151
- LYBALVI$1,801
- INGREZZA$1,578
- AUSTEDO$991
- ARISTADA$882
- UZEDY$727
- Austedo XR$725
- INVEGA SUSTENNA$528
- REXULTI$494
- ABILIFY MAINTENA$349
- COBENFY$285
- CAPLYTA$232
- Auvelity$227
- ARISTADA INITIO$221
- SPRAVATO$125
- ABILIFY ASIMTUFII$125
- INVEGA TRINZA$125
- VIVITROL$125
How this compares
$12,780 in reported general payments places this provider in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 22 | $165,176 |
| Invega SustennaPaliperidone Palmitate | 38 | $138,062 |
| VraylarCariprazine Hcl | 25 | $38,073 |
| Abilify MaintenaAripiprazole | 12 | $27,117 |
| Divalproex Sodium ErDivalproex Sodium | 27 | $3,372 |
| Quetiapine Fumarate | 52 | $1,321 |
| Risperidone | 27 | $793 |
| Benztropine Mesylate | 54 | $696 |
| Divalproex Sodium | 18 | $692 |
| Olanzapine | 43 | $662 |
| Hydroxyzine Hcl | 17 | $507 |
| Propranolol Hcl | 18 | $238 |
| Lithium Carbonate | 13 | $114 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $2,162 | $165,17622 claims |
| Johnson & JohnsonInvega Sustenna | $1,192 | $138,06238 claims |
| AbbVieVraylar | $2,945 | $38,07325 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $1,279 | $27,11712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.
Other psychiatric/mental health in Waco
- Marguerite AddisonWaco$118K
- Tracy HicksLongview$684K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
- Monique GonzalezSan Antonio$126K
- Komi Kokou-AbiRound Rock$88K
- Jaime Nelson DensonAustin$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.